Literature DB >> 19610654

Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation.

Richard M LoPachin1, Terrence Gavin, Dennis R Petersen, David S Barber.   

Abstract

Acrolein and 4-hydroxy-2-nonenal (HNE) are byproducts of lipid peroxidation and are thought to play central roles in various traumatic injuries and disease states that involve cellular oxidative stress, for example, spinal cord trauma, diabetes, and Alzheimer's disease. In this review, we will discuss the chemical attributes of acrolein and HNE that determine their toxicities. Specifically, these aldehydes are classified as type 2 alkenes and are characterized by an alpha,beta-unsaturated carbonyl structure. This structure is a conjugated system that contains mobile pi-electrons. The carbonyl oxygen atom is electronegative and can promote the withdrawal of mobile electron density from the beta-carbon atom causing regional electron deficiency. On the basis of this type of electron polarizability, both acrolein and HNE are considered to be soft electrophiles that preferentially form 1,4-Michael type adducts with soft nucleophiles. Proteomic, quantum mechanical, and kinetic data will be presented, indicating that cysteine sulfhydryl groups are the primary soft nucleophilic targets of acrolein and HNE. This is in contrast to nitrogen groups on harder biological nucleophiles such as lysine or histidine residues. The toxicological outcome of adduct formation is not only dependent upon residue selectivity but also the importance of the targeted amino acid in protein function or structure. In attempting to discern the toxicological significance of a given adduct, we will consider the normal roles of cysteine, lysine, and histidine residues in proteins and the relative merits of corresponding adducts in the manifestations of diseases or toxic states. Understanding the molecular actions of acrolein and HNE could provide insight into many pathogenic conditions that involve initial cellular oxidative stress and could, thereby, offer new efficacious avenues of pharmacological defense.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19610654      PMCID: PMC4452948          DOI: 10.1021/tx900147g

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  111 in total

Review 1.  Nitrosylation. the prototypic redox-based signaling mechanism.

Authors:  J S Stamler; S Lamas; F C Fang
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

2.  Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry.

Authors:  B A Bruenner; A D Jones; J B German
Journal:  Chem Res Toxicol       Date:  1995-06       Impact factor: 3.739

3.  4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal.

Authors:  De Lin; Hyoung-gon Lee; Quan Liu; George Perry; Mark A Smith; Lawrence M Sayre
Journal:  Chem Res Toxicol       Date:  2005-08       Impact factor: 3.739

4.  Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal.

Authors:  Giancarlo Aldini; Luca Gamberoni; Marica Orioli; Giangiacomo Beretta; Luca Regazzoni; Roberto Maffei Facino; Marina Carini
Journal:  J Mass Spectrom       Date:  2006-09       Impact factor: 1.982

5.  Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction.

Authors:  Giancarlo Aldini; Isabella Dalle-Donne; Giulio Vistoli; Roberto Maffei Facino; Marina Carini
Journal:  J Mass Spectrom       Date:  2005-07       Impact factor: 1.982

Review 6.  Protein S-nitrosylation: purview and parameters.

Authors:  Douglas T Hess; Akio Matsumoto; Sung-Oog Kim; Harvey E Marshall; Jonathan S Stamler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

7.  Acrolein-induced oxygen radical formation.

Authors:  J D Adams; L K Klaidman
Journal:  Free Radic Biol Med       Date:  1993-08       Impact factor: 7.376

Review 8.  Intracellular metabolism of 4-hydroxynonenal.

Authors:  Werner Siems; Tilman Grune
Journal:  Mol Aspects Med       Date:  2003 Aug-Oct

9.  Neurotoxic mechanisms of electrophilic type-2 alkenes: soft soft interactions described by quantum mechanical parameters.

Authors:  Richard M LoPachin; Terrence Gavin; Brian C Geohagen; Soma Das
Journal:  Toxicol Sci       Date:  2007-05-22       Impact factor: 4.849

10.  Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE.

Authors:  Suresh P Annangudi; Yijun Deng; Xiaorong Gu; Wujuan Zhang; John W Crabb; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2008-06-21       Impact factor: 3.739

View more
  98 in total

1.  Site-specific proteomic analysis of lipoxidation adducts in cardiac mitochondria reveals chemical diversity of 2-alkenal adduction.

Authors:  Juan D Chavez; Jianyong Wu; William Bisson; Claudia S Maier
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

2.  4-HNE adduct stability characterized by collision-induced dissociation and electron transfer dissociation mass spectrometry.

Authors:  Kristofer S Fritz; Katherine A Kellersberger; Jose D Gomez; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2012-03-28       Impact factor: 3.739

3.  Posttranslational modification and regulation of glutamate-cysteine ligase by the α,β-unsaturated aldehyde 4-hydroxy-2-nonenal.

Authors:  Donald S Backos; Kristofer S Fritz; James R Roede; Dennis R Petersen; Christopher C Franklin
Journal:  Free Radic Biol Med       Date:  2010-10-21       Impact factor: 7.376

4.  Protein carbonylation in a murine model for early alcoholic liver disease.

Authors:  James J Galligan; Rebecca L Smathers; Kristofer S Fritz; L E Epperson; Lawrence E Hunter; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2012-05-01       Impact factor: 3.739

5.  Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress.

Authors:  Lonnie Schneider; Samantha Giordano; Blake R Zelickson; Michelle S Johnson; Gloria A Benavides; Xiaosen Ouyang; Naomi Fineberg; Victor M Darley-Usmar; Jianhua Zhang
Journal:  Free Radic Biol Med       Date:  2011-09-01       Impact factor: 7.376

6.  Glutathione transferase A4-4 resists adduction by 4-hydroxynonenal.

Authors:  Laura M Shireman; Kimberly A Kripps; Larissa M Balogh; Kip P Conner; Dale Whittington; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2010-09-15       Impact factor: 4.013

7.  The tobacco smoke component acrolein induces glucocorticoid resistant gene expression via inhibition of histone deacetylase.

Authors:  Matthew J Randall; Guido R M M Haenen; Freek G Bouwman; Albert van der Vliet; Aalt Bast
Journal:  Toxicol Lett       Date:  2015-10-19       Impact factor: 4.372

8.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

9.  4-Hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by β oxidation of fatty acids in the isolated rat heart.

Authors:  Qingling Li; Sushabhan Sadhukhan; Jessica M Berthiaume; Rafael A Ibarra; Hui Tang; Shuang Deng; Eric Hamilton; Laura E Nagy; Gregory P Tochtrop; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

10.  Phenelzine Protects Brain Mitochondrial Function In Vitro and In Vivo following Traumatic Brain Injury by Scavenging the Reactive Carbonyls 4-Hydroxynonenal and Acrolein Leading to Cortical Histological Neuroprotection.

Authors:  John E Cebak; Indrapal N Singh; Rachel L Hill; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.